After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Tenaya Therapeutics Inc is $221.46M. A total of 1.59 million shares were traded on the day, compared to an average of 3.74M shares.
In the most recent transaction, Higa Tomohiro sold 1,367 shares of TNYA for 1.33 per share on Nov 17 ’25. After the transaction, the SVP, Finance now owns 93,971 company shares. In a previous transaction on Nov 17 ’25, Tingley Whittemore sold 2,877 shares at 1.33 per share. TNYA shares that Chief Medical Officer owns now total 169,926.
Among the insiders who sold shares, Ali Faraz disposed of 3,126 shares on Nov 17 ’25 at a per-share price of $1.33. This resulted in the Chief Executive Officer holding 299,666 shares of TNYA after the transaction. In another insider transaction, Higa Tomohiro sold 2,962 shares at $1.25 per share on Aug 18 ’25. Company shares held by the SVP, Finance now total 95,338.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, TNYA has a high of $4.01 and a low of $0.36.
As of this writing, TNYA has an earnings estimate of -$0.15 per share for the current quarter. EPS was calculated based on a consensus of 8.0 estimates, with a high estimate of -$0.11 per share and a lower estimate of -$0.22. The company reported an EPS of -$0.28 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. TNYA’s latest balance sheet shows that the firm has $251.30M in Cash & Short Term Investments as of fiscal 2021. There were $15.70M in debt and $21.77M in liabilities at the time. Its Book Value Per Share was $0.51, while its Total Shareholder’s Equity was $278.53M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TNYA is Buy with a score of 4.80.
